Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • CCC Cancer Update
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Frontiers in neuroscience. 2021 Oct 12. doi: 10.3389/fnins.2021.761654. pmc: PMC8546107
    Retinal Oxygen Metabolism and Haemodynamics in Patients With Multiple Sclerosis and History of Optic Neuritis.
    Kallab M1,  Hommer N2,  Schlatter A3,  Bsteh G4,  Altmann P5,  Popa-Cherecheanu A6,  Pfister M7,  Werkmeister RM8,  Schmidl D9,  Schmetterer L10,  Garhöfer G11
    Author information
    1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
    2Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
    3Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
    4Department of Neurology, Medical University of Vienna, Vienna, Austria.
    5Department of Neurology, Medical University of Vienna, Vienna, Austria.
    6Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
    7Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
    8Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
    9Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
    10Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
    11Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
    Abstract

    Vascular changes and alterations of oxygen metabolism are suggested to be implicated in multiple sclerosis (MS) pathogenesis and progression. Recently developed in vivo retinal fundus imaging technologies provide now an opportunity to non-invasively assess metabolic changes in the neural retina. This study was performed to assess retinal oxygen metabolism, peripapillary capillary density (CD), large vessel density (LVD), retinal nerve fiber layer thickness (RNFLT) and ganglion cell inner plexiform layer thickness (GCIPLT) in patients with diagnosed relapsing multiple sclerosis (RMS) and history of unilateral optic neuritis (ON). 16 RMS patients and 18 healthy controls (HC) were included in this study. Retinal oxygen extraction was modeled using O saturations and Doppler optical coherence tomography (DOCT) derived retinal blood flow (RBF) data. CD and LVD were assessed using optical coherence tomography (OCT) angiography. RNFLT and GCIPLT were measured using structural OCT. Measurements were performed in eyes with (MS+ON) and without (MS-ON) history for ON in RMS patients and in one eye in HC. Total oxygen extraction was lowest in MS+ON (1.8 ± 0.2 μl O/min), higher in MS-ON (2.1 ± 0.5 μl O/min, = 0.019 vs. MS+ON) and highest in HC eyes (2.3 ± 0.6 μl O/min, = 0.002 vs. MS, ANOVA = 0.031). RBF was lower in MS+ON (33.2 ± 6.0 μl/min) compared to MS-ON (38.3 ± 4.6 μl/min, = 0.005 vs. MS+ON) and HC eyes (37.2 ± 4.7 μl/min, = 0.014 vs. MS+ON, ANOVA = 0.010). CD, LVD, RNFLT and GCIPL were significantly lower in MS+ON eyes. The present data suggest that structural alterations in the retina of RMS patients are accompanied by changes in oxygen metabolism, which are more pronounced in MS+ON than in MS-ON eyes. Whether these alterations promote MS onset and progression or occur as consequence of disease warrants further investigation. ClinicalTrials.gov registry, NCT03401879.


    Copyright © 2021 Kallab, Hommer, Schlatter, Bsteh, Altmann, Popa-Cherecheanu, Pfister, Werkmeister, Schmidl, Schmetterer and Garhöfer.

    KEYWORDS: microcirculation, multiple sclerosis, optical coherence tomography angiography, retinal blood flow, retinal oxygen saturation

    Publikations ID: 34712117
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt